Red Light Therapy for Eyes

Red light therapy for eye health is one of the most intriguing — and most misunderstood — applications of photobiomodulation. Unlike most red light applications where you shine light at tissue, ocular red light therapy uses the eye’s own optical pathway to deliver light directly to the retina, where mitochondria in photoreceptors can absorb it.

This is also an area where safety protocols matter more than anywhere else. The same optical properties that make the eye uniquely receptive to therapeutic light also make it uniquely vulnerable to damage from incorrect use. This guide covers both the evidence and the essential safety framework.

Affiliate disclosure: This page contains affiliate links. If you purchase through our links, we may earn a commission at no additional cost to you. This does not influence our editorial judgement.

The Evidence: What Red Light Does in the Eye

Retinal mitochondrial function

The foundational research on red light and the retina comes from Professor Glen Jeffery’s lab at University College London, in collaboration with the Nuffield Laboratory of Ophthalmology. Their findings, published in Journals of Gerontology (2020) and Scientific Reports (2023), established several key points:

• Retinal photoreceptors (rods and cones) have extremely high metabolic demands and accumulate mitochondrial dysfunction with age
• Brief daily exposure to 670 nm red light in humans aged 34–70 improved colour contrast sensitivity by an average of 17% — and the improvement persisted
• 670 nm light improves the performance of cone ATP synthesis, effectively “recharging” retinal mitochondria
• The mechanism is the same as systemic photobiomodulation: cytochrome c oxidase activation increasing ATP production in the photoreceptor inner segments

Why 670 nm specifically? This wavelength sits at a peak absorption trough for water (which would otherwise absorb incident light before it reaches the retina) while remaining within the activation range for cytochrome c oxidase. It penetrates the eye’s media and reaches the retinal layer with minimal attenuation.

Circadian rhythm modulation

Red light in the 630–670 nm range does not activate the intrinsically photosensitive retinal ganglion cells (ipRGCs) that drive melanopsin-based melatonin suppression. This is the same mechanism that makes blue light from screens damaging to sleep. Red light reaches the eye without triggering the melatonin-suppressing pathway, making evening exposure compatible with natural circadian function. This has implications for sleep quality — see our red light therapy for sleep guide for more on this.

For the broader clinical picture on eye research, see our conditions page on eye research.

Safety: This Must Come First

Critical safety rules for ocular red light therapy:

1. Never use near-infrared (NIR) wavelengths (800 nm+) directly aimed at eyes. NIR light is invisible, so your pupillary reflex — which constricts to protect your retina from bright visible light — does not activate. NIR directed at the eye risks retinal thermal injury without any warning signal. All ocular red light protocols use visible red (630–680 nm), not NIR.

2. Use only low-irradiance devices at specified distances. The Jeffery protocol uses 4 mW/cm² at 5 cm for 3 minutes. Consumer devices vary — check the manual for ocular-safe settings. High-power panels at close range are not designed for eye use and should not be directed at eyes even with standard eye protection.

3. Do not use standard tanning goggles as “eye protection” for ocular RLT. Standard eye protection blocks all light — it is designed to prevent any ocular exposure. For intentional ocular therapy, you need either no eye protection (as in the Jeffery protocol) or purpose-designed, irradiance-limited devices.

4. Contraindications: Avoid ocular red light therapy if you have: active retinal disease (wet AMD with active neovascularisation), glaucoma with poorly controlled IOP, history of retinal detachment, are taking photosensitising medications, or have had recent eye surgery. Consult an ophthalmologist first.

5. Never look directly at high-power LED panels (even those with standard eye protection). General-purpose red light panels are not calibrated for ocular use.

Best Devices for Ocular Red Light Therapy

For eye applications, you want devices specifically designed for the purpose — low irradiance, correct wavelength (670 nm), purpose-built for controlled ocular exposure. General full-body panels are not appropriate for direct eye use.

Device	Type	Wavelength	Notes	Price (approx.)	Buy
Joovv Go 2.0	Handheld	660 + 850 nm	Use at arm’s length, eyes closed for NIR; eyes open at 30+ cm for red	£150–200	Amazon{rel=“nofollow sponsored noopener noreferrer” target=“_blank”}
Hooga HG200	Small panel	660 + 850 nm	Versatile, use at 30–60 cm distance for facial/eye-adjacent use	£80–120	Amazon{rel=“nofollow sponsored noopener noreferrer” target=“_blank”}
Red light wand (handheld)	Handheld	630–670 nm	Low-irradiance handheld wands; best for gentle periorbital and ocular-adjacent use	£30–80	Amazon{rel=“nofollow sponsored noopener noreferrer” target=“_blank”}

Note: Dedicated ocular red light devices (such as those used in clinical trials) are not yet widely available at consumer price points. The devices above are used for periorbital and general facial red light therapy. For strict replication of the Jeffery protocol, a low-power 670 nm source (LED torch or similar) at measured distance is what the research actually uses.

See our handheld red light therapy guide for more on portable device options.

How to Use Red Light Therapy for Eye Health

Protocol based on Jeffery et al. (2023)

• Wavelength: 670 nm
• Irradiance: ~4 mW/cm² at the eye
• Duration: 3 minutes
• Frequency: Once daily (or every other day — data shows daily use maintains benefit)
• Method: Look toward the light source (eyes open, blinks permitted) for the duration. Early morning appears to produce the strongest response — the Jeffery team observed time-of-day effects, with morning sessions showing greater benefit than afternoon
• Distance: Calibrate to achieve ~4 mW/cm² at eye level. This will vary by device — most consumer panels are far too powerful at close range and need to be used at greater distance

Circadian use

For circadian rhythm support (avoiding blue light at night), red-filtered bulbs or low-power red LEDs in the evening bedroom environment can be used without looking directly at any source. The goal is general ambient red light rather than directed ocular therapy.

What to Look For

670 nm is the validated wavelength. Some devices offer 630 nm or 660 nm — these are close enough that meaningful absorption likely occurs, but the Jeffery research specifically used 670 nm. Precision matters more here than in many other red light applications because you are targeting a specific photoreceptor population.

Low irradiance is essential. The therapeutic dose for the retina is very low — 4 mW/cm² for 3 minutes delivers about 0.7 J/cm². General-purpose red light panels deliver 100–200 mW/cm² at close range — orders of magnitude higher. Low-powered handheld devices or purposefully built ocular tools are appropriate; high-power panels are not.

No NIR for direct eye use. Any device with significant 800+ nm output should not be directed at open eyes, regardless of any safety claims.

Frequently Asked Questions

Is red light therapy safe for eyes?

At the correct protocol — 670 nm, low irradiance, 3 minutes — the evidence suggests it is not only safe but beneficial. The risk emerges from incorrect use: high irradiance, near-infrared wavelengths, or prolonged exposure. Follow the protocol, use appropriate devices, and consult an ophthalmologist if you have any existing eye conditions.

Can red light therapy improve eyesight?

The Jeffery studies showed improved colour contrast sensitivity (a measure of cone function) in healthy adults. This is not the same as improving visual acuity (the “20/20” measure) or reversing diagnosed conditions. The effect appears to be mitochondrial optimisation — restoring age-related decline in photoreceptor energy production — rather than structural repair.

What is the best time of day for ocular red light therapy?

The Jeffery team’s data suggests morning exposure produces a larger benefit than afternoon sessions, possibly related to the circadian state of retinal mitochondria. Early morning, before full light exposure, appears optimal.

Can red light therapy help with macular degeneration?

Early and dry AMD involve photoreceptor mitochondrial dysfunction — the same mechanism that red light therapy addresses. This is one reason the Jeffery research is particularly watched by the AMD research community. However, this is not yet a standard clinical recommendation. See our eye research conditions page for the current evidence status. Always consult an ophthalmologist before using any device if you have AMD.

Can I use a standard red light panel for eye therapy?

No. Standard panels are designed for skin and musculoskeletal applications and emit irradiances that are far too high for direct ocular use. Handheld low-power devices or purpose-built tools at appropriate distance are required.

Summary

Red light therapy for eye health has moved from speculative to genuinely evidence-supported in the last five years, primarily through the work of Jeffery et al. at UCL. The mechanism — photoreceptor mitochondrial activation at 670 nm — is well-characterised and clinically plausible. Brief daily sessions appear capable of improving age-related decline in colour contrast sensitivity.

Safety is the essential framework here: correct wavelength (670 nm visible red, not NIR), low irradiance (~4 mW/cm²), short sessions (3 minutes), and medical clearance for anyone with existing eye disease.

For handheld devices suitable for gentle periorbital use, see our handheld red light therapy guide.

Browse 670nm red light therapy devices on Amazon{rel=“nofollow sponsored noopener noreferrer” target=“_blank”}